Federal contract award
W81K0226FA042
DIASORIN MOLECULAR LIAISON MDX KITS - DELIVERY ORDER
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY HCD WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | W81K0226DA005 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $61.6K |
| Current contract value | $61.6K |
| Potential contract value / ceiling | $61.6K |
| Start date | Oct 1, 2025 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | May 27, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 27, 2026 | P00002 | $0 | DIASORIN MOLECULAR LIAISON KITS |
| Apr 7, 2026 | P00001 | $0 | DIASORIN MOLECULAR LIAISON MDX KITS - DELIVERY ORDER |
| Oct 1, 2025 | 0 | $61.6K | DIASORIN MOLECULAR LIAISON MDX KITS - DELIVERY ORDER |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.